Experts suggest that new real-time live-cell imaging platforms could transform cancer drug discovery by allowing researchers to observe cellular behavior continuously rather than through static autopsies.
Dr. Shyam Aggarwal of Sir Ganga Ram Hospital noted that these technologies help identify promising therapies more efficiently during preclinical research by tracking subtle biochemical changes.
India reported 1.4 million new cancer cases in 2022, according to IARC data, with the ICMR projecting a continued rise in the national cancer burden over the next decade.